With experience and know-how in natural product biosynthesis, a milestone-based approach to projects, innovation and flexibility, as well as competitive pricing, Acies Bio aims to become the premier partner in R&D outsourcing for a number of major pharmaceutical companies.

Acies Bio's main strengths include the manipulation of secondary metabolites, the improvement of industrial strains and impurity profiles, media optimization and the development of bioprocesses. Through its own research program, it develops new patentable technologies and processes for the production of important pharmaceutical substances.

In its new active substance discovery program, Acies Bio searches for and develops new secondary metabolites with a particular focus on compounds with anti-tumour, anti-inflammatory, anti-bacterial, anti-fungal and neuro-regenerative activities.

Acies Bio won the Slovenian Startup of the Year award in 2008!